Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis

Auris Nasus Larynx

Volumn 35, Issue 1, 2008, Pages 61-66

  Pinar, Ercan ^a   Eryigit, Ozge ^a   Oncel, Semih ^a   Calli, Caglar ^a   Yilmaz, Ozge ^b   Yuksel, Hasan ^b  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Allergic rhinitis; Antihistamine; Leukotriene receptor antagonists; Nasal peak inspiratory flow; Quality of life

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; DESLORATADINE; MOMETASONE FUROATE; MONTELUKAST; PLACEBO;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE;

ACETATES; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-ALLERGIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; INTRADERMAL TESTS; LEUKOTRIENE ANTAGONISTS; LORATADINE; MALE; MIDDLE AGED; PREGNADIENEDIOLS; PULMONARY VENTILATION; QUALITY OF LIFE; QUINOLINES; RHINITIS, ALLERGIC, SEASONAL;

EID: 37749020311     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2007.06.004     Document Type: Article

References (33)

1. Lundback B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 28 Suppl 2 (1998) 3-10
2. Bousquet J., van Cauwenberge P., and Khaltaev N. Allergic rhinitis and its impact on asthma. ARIA workshop report in collaboration with the World Health Organisation 2001. J Allergy Clin Immunol 108 Suppl 5 (2001) S147-S334
3. Thompson A.K., Juniper E., and Meltzer E.O. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 85 (2000) 338-348
4. Bousquet J. Quality of life in allergic rhinitis. Clin Exp Allergy Rev 2 (2002) 55
5. Vuurman E.F., van-Veggel L.M., Uiterwijk M.M., Leutner D., and O'Hanlon J.F. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 71 (1993) 121-126
6. Lund V.J. International consensus report on the diagnosis and management of rhinitis. International rhinitis management working group. Allergy 49 Suppl 19 (1994) 1-34
7. van Cauwenberge P., Bachert C., Passalacqua G., Bousquet J., Canonica G.W., Durham S.R., et al. Consensus statement on the treatment of allergic rhinitis. European academy of allergology and clinical immunology. Allergy 55 (2000) 116-134
8. Horak F., Stübner U.P., Zieglmayer R., and Harris A.G. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure. Allergy 58 (2003) 481-485
9. Pulleritis T., Praks L., Skoogh B.E., Ani R., and Lotvall J. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Am J Respir Crit Care Med 159 (1999) 1814-1818
10. Youlten L.J.F. The peak nasal inspiratory flow meter: a new instrument for the assessment of the response to immunotherapy in seasonal allergic rhinitis. Allergol Immunopathol 8 (1980) 344
11. Holmström M., Scadding G.K., Lund V.J., and Darby Y.C. The assessment of nasal obstruction-a comparison between rhinomanometry and nasal inspiratory peak flow. Rhinology 28 (1990) 191-196
12. Wihl J.A., and Malm L. Rhinomanometry and nasal peak expiratory and inspiratory flow rate. Ann Allergy 61 (1988) 50-55
13. Bergner M., Bobbitt R.A., Carter W.B., and Gilson B.S. The sickness impact profile: development and final revision of a health status measure. Med Care 19 (1981) 787-805
14. Stewart A.L., Hays R., and Ware J.E. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 26 (1988) 724-732
15. Juniper E.F., and Guyatt Gh. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 21 (1991) 77-83
16. Spector S.L. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol 99 (1997) S773-S780
17. Craig T.J., McCann J.L., Gurevich F., and Davies M.J. The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol 114 (2004) S139-S145
18. Bernstein J.M. The role of IgE-mediated hypersensitivity in the development of otitis media with effusion: a review. Otolaryngol Head Neck Surg 109 (1993) 611-620
19. Mygind N. Glucocorticosteroids and rhinitis. Allergy 48 (1993) 476-490
20. Kondo H., Nachtigal D., Frenkiel S., Schotman E., and Hamid O. Effects of steroids on nasal inflammatory cells and cytokine profile. Laryngoscope 109 (1999) 91-97
21. Corren J. Intranasal corticosteroids for allergic rhinitis: how do different agents compare?. J Allergy Clin Immunol 104 (1999) S144-S149
22. Di Lorenzo G., Pacor M.L., Pellitteri M.E., Morici G., Di Gregoli A., Lo Bianco C., et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine, plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy 34 (2004) 259-267
23. Meltzer E.O., Philip G., and Weinstein S.F. Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis. Am J Rhinol 19 6 (2005) 591-598
24. Grossman J., Ratner P.H., Nathan R., Adelglass J., and de Jong B. Pranlukast (Ultair, SB 205312, ONO-1078), an oral leukotriene receptor antagonist, relieves symptoms in patients with seasonal allergic rhinitis (SAR). J Allergy Clin Immunol 99 (1997) S443
25. Meltzer E.O., Malmstorm K., Lu S., Prenner B.M., Wei L.X., Weinstein S.F., et al. Concomitant montelukast and loratidine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 105 (2000) 917-922
26. Nayak A.J., Philip G., Lu S., Malice M.P., and Reiss T.F. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol 88 (2002) 592-600
27. Juniper E.F., Thompson A.K., and Roberts J.N. Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36. Allergy 57 (2002) 201-206
28. Juniper E.F., Guyatt G.H., Anderson B., and Ferrie P.J. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy 70 (1993) 225-230
29. Philip G., Malmstrom K., Hampel F.C., Weinstein S.F., La Force C.F., Ratner P.H., et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 32 (2002) 1020-1028
30. Potter P.C., Van Niekerk C.H., and Schoeman H.S. Effects of triamcinolone on quality of life in patients with persistent allergic rhinitis. Ann Allergy Asthma Immunol 91 4 (2003) 368-374
31. Bende M., Carrillo T., Vona I., Castel-Branco M.G., and Arheden L. A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis. Ann Allergy Asthma Immunol 88 (2002) 617-623
32. Wilson A.M., Dempsey O.J., Sims E.J., Coutie W.J.R., Paterson M.C., and Lipworth B.J. Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow. Clin Exp Allergy 30 (2000) 833-838
33. Wilson A.M., Sims E.J., Orr L.C., Coutie W.J.R., White P.S., Gardiner Q., et al. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis. Ann Allergy Asthma Immunol 87 (2001) 344-349